MLM Stock Analysis: Martin Marietta Materials | NYSE
Building Materials | NYSE, USA | Market Cap: 32.130m USD | 12M Return: -11% | US5732841060 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 319M
EPS Trend: 19.0%
Qual. Beats: 1
Rev. Trend: -27.7%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Martin Marietta Materials, Inc. is a natural resource-based building materials company that supplies aggregates (crushed stone, sand, and gravel) and heavy-side building materials, including ready mixed concrete, asphalt, and paving products and services, to construction markets across the United States and internationally. The company reports through two geographic segments, East Group and West Group, and serves infrastructure, nonresidential, and residential construction end-markets, as well as the railroad, agricultural, utility, and environmental industries. Beyond aggregates, it produces magnesia-based chemicals and dolomitic lime used in steel production, soil stabilization, flame retardants, wastewater treatment, and pulp and paper applications. The company was founded in 1939 and is headquartered in Raleigh, North Carolina.
Operating within the GICS Construction Materials sub-industry, Martin Marietta benefits from a vertically integrated quarry-to-product model in which aggregate reserves are the primary economic moat, as nearby permitted sources are difficult to replicate. Demand for its products is closely tied to public infrastructure spending, private nonresidential construction cycles, and residential housing activity, making the business sensitive to interest rates, government funding programs (such as federal highway allocations), and regional construction trends.
- Infrastructure bill spending drives aggregates demand and pricing power
- Magnesia chemicals margins track steel production and industrial demand
- Acquisition strategy expands aggregates reserves in Sun Belt markets
| Net Income: 2.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.53 > 1.0 |
| NWC/Revenue: 10.45% < 20% (prev 20.56%; Δ -10.11% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.52b > Net Income 2.46b |
| Net Debt (6.23b) to EBITDA (2.08b): 2.99 < 3 |
| Current Ratio: 1.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (60.2m) vs 12m ago -0.33% < -2% |
| Gross Margin: 28.17% > 18% (prev 29.44%; Δ -1.28% > 0.5%) |
| Asset Turnover: 33.98% > 50% (prev 36.99%; Δ -3.01% > 0%) |
| Interest Coverage Ratio: 6.05 > 6 (EBIT TTM 1.40b / Interest Expense TTM 231.0m) |
| A: 0.03 (Total Current Assets 2.44b - Total Current Liabilities 1.74b) / Total Assets 21.3b |
| B: 0.37 (Retained Earnings 7.86b / Total Assets 21.3b) |
| C: 0.07 (EBIT TTM 1.40b / Avg Total Assets 19.7b) |
| D: 1.18 (Book Value of Equity 11.5b / Total Liabilities 9.76b) |
| Altman-Z'' = 3.14 = A |
| DSRI: 1.13 (Receivables 1.02b/904.0m, Revenue 6.69b/6.68b) |
| GMI: 1.05 (GM 29.44% / 28.17%) |
| AQI: 0.88 (AQ_t 0.25 / AQ_t-1 0.29) |
| SGI: 1.00 (Revenue 6.69b / 6.68b) |
| TATA: 0.04 (NI 2.46b - CFO 1.52b) / TA 21.3b) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of August 24, 2026, the stock is trading at USD 534.92 with a total of 459,228 shares traded. Over the past week, the price has changed by -2.37%, over one month by -2.19%, over three months by -4.50% and over the past year by -11.04%.
Current recommended Stop Loss: 513.20 (which is 4.1% or 1.4 ATR below the current price).
Martin Marietta Materials has received a consensus analysts rating of 4.04. Therefore, it is recommended to buy MLM.
- StrongBuy: 11
- Buy: 4
- Hold: 7
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 662.7 | 23.9% |
P/E Trailing = 34.7125
P/E Forward = 28.49
P/S = 4.8042
P/B = 2.7828
P/EG = 2.6512
Revenue TTM = 6.69b USD
EBIT TTM = 1.40b USD
EBITDA TTM = 2.08b USD
Long Term Debt = 5.09b USD (from longTermDebt, last quarter)
Short Term Debt = 860.0m USD (from shortTermDebt, last quarter)
Debt = 6.34b USD (from shortLongTermDebtTotal, last quarter) + Leases 394.0m
Net Debt = 6.23b USD (calculated: Debt 6.34b - CCE 112.0m)
Enterprise Value = 38.4b USD (32.1b + Debt 6.34b - CCE 112.0m)
Interest Coverage Ratio = 6.05 (Ebit TTM 1.40b / Interest Expense TTM 231.0m)
EV/FCF = 47.36x (Enterprise Value 38.4b / FCF TTM 810.0m)
FCF Yield = 2.11% (FCF TTM 810.0m / Enterprise Value 38.4b)
FCF Margin = 12.11% (FCF TTM 810.0m / Revenue TTM 6.69b)
Net Margin = 36.81% (Net Income TTM 2.46b / Revenue TTM 6.69b)
Gross Margin = 28.17% ((Revenue TTM 6.69b - Cost of Revenue TTM 4.80b) / Revenue TTM)
Gross Margin QoQ = 25.42% (prev 22.76%)
Tobins Q-Ratio = 1.80 (Enterprise Value 38.4b / Total Assets 21.3b)
Interest Expense / Debt = 3.64% (Interest Expense 231.0m / Debt 6.34b)
Taxrate = 20.33% (237.0m / 1.17b)
NOPAT = 1.11b (EBIT 1.40b * (1 - 20.33%))
Current Ratio = 1.40 (Total Current Assets 2.44b / Total Current Liabilities 1.74b)
Debt / Equity = 0.55 (Debt 6.34b / totalStockholderEquity, last quarter 11.5b)
Debt / EBITDA = 2.99 (Net Debt 6.23b / EBITDA 2.08b)
Debt / FCF = 7.70 (Net Debt 6.23b / FCF TTM 810.0m)
Total Stockholder Equity = 10.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.51% (Net Income 2.46b / Total Assets 21.3b)
RoE = 23.11% (Net Income TTM 2.46b / Total Stockholder Equity 10.7b)
RoCE = 8.87% (EBIT 1.40b / Capital Employed (Equity 10.7b + L.T.Debt 5.09b))
RoIC = 5.48% (NOPAT 1.11b / Invested Capital 20.3b)
WACC = 7.43% (E(32.1b)/V(38.5b) * Re(8.33%) + D(6.34b)/V(38.5b) * Rd(3.64%) * (1-Tc(0.20)))
Discount Rate = 8.33% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.83 | Cagr: -1.30%
[DCF] Terminal Value 73.10% ; FCFF base≈871.2m ; Y1≈764.0m ; Y5≈617.3m
[DCF] Fair Price = 61.18 (EV 9.91b - Net Debt 6.23b = Equity 3.67b / Shares 60.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 19.00 | EPS CAGR: 0.66% | SUE: 1.65 | # QB: 1
Revenue Correlation: -27.65 | Revenue CAGR: -0.36% | SUE: 0.84 | # QB: 1
EPS current Quarter (2026-09-30): EPS=6.76 | Chg30d=-8.85% | Revisions=-58% | Analysts=12
EPS current Year (2026-12-31): EPS=18.40 | Chg30d=-3.65% | Revisions=-44% | GrowthEPS=-2.0% | GrowthRev=+18.4%
EPS next Year (2027-12-31): EPS=21.52 | Chg30d=-5.68% | Revisions=-45% | GrowthEPS=+17.0% | GrowthRev=+7.3%
[Analyst] Revisions Ratio: -55% (up=8, down=31)